Literature DB >> 23027364

Instrumented Minimally Invasive Spinal-Transforaminal Lumbar Interbody Fusion (MIS-TLIF): Minimum 5-Year Follow-Up With Clinical and Radiologic Outcomes.

Jin-Sung Kim1, Byungjoo Jung, Sang-Ho Lee.   

Abstract

STUDY
DESIGN: A retrospective study.
OBJECTIVE: To determine the clinical and radiologic outcomes of the long-term results of instrumented minimally invasive spinal-transforaminal lumbar interbody fusion (MIS-TLIF) in unstable, single-level, low-grade, isthmic spondylolisthesis (IS) or degenerative spondylosis (DS) including degenerative spondylolisthesis, foraminal stenosis with central stenosis, degenerative disk disease, and recurrent disk herniation. SUMMARY OF BACKGROUND DATA: MIS-TLIF is a common surgical procedure to treat lumbar spondylolisthesis. However, there are no studies that have documented the long-term results of MIS-TLIF.
METHODS: Forty-four patients who had undergone instrumented MIS-TLIF between July 2003 and January 2005 were retrospectively reviewed. The visual analog scale, Oswestry Disability Index, patient satisfaction rate, and the patient's return-to-work status were used to assess clinical and functional outcomes. Radiologic follow-up were carried out in patients to check for adjacent segmental degeneration (ASD). The plain radiographs, computed tomography and magnetic resonance imaging, were used in all patients in last follow-up period.
RESULTS: The mean visual analog scale scores for back and leg pain decreased from 5.8 and 7 to 3.5 and 3.7, respectively, in the DS group (n=19) and from 6.8 and 6.9 to 1.8 and 2.0, respectively, in the IS group (n=25) (P<0.001). The mean Oswestry Disability Index scores improved from 61.7% to 21.5% in the DS group and from 53.9% to 16% in the IS group (P<0.001). Patient satisfaction rate was 80% and 81% in the DS and IS groups, respectively. Evidence of fusion was observed radiologically in 24 (96%) and 19 (100%) of the patients in the IS and the DS group, respectively, giving an overall fusion rate of 97.7% (43/44). The final ASD rate, observed using radiography, was 68.4% (13/19) in the DS and 40% (10/25) in the IS group. However, 15.8% (3/19) in the DS and 4% (1/25) in the IS group had symptoms associated with ASD.
CONCLUSIONS: The long-term clinical and radiologic outcomes after instrumented MIS-TLIF in patients with unstable single-level spine are favorable.

Entities:  

Mesh:

Year:  2018        PMID: 23027364     DOI: 10.1097/BSD.0b013e31827415cd

Source DB:  PubMed          Journal:  Clin Spine Surg        ISSN: 2380-0186            Impact factor:   1.876


  34 in total

1.  Minimally invasive transforaminal lumbar interbody fusion for lumbar spondylolisthesis.

Authors:  Islam M Elboghdady; Abbas Naqvi; Anton Y Jorgenson; Alejandro Marquez-Lara; Kern Singh
Journal:  Ann Transl Med       Date:  2014-10

2.  Percutaneous Transforaminal Lumbar Interbody Fusion (pTLIF) with a Posterolateral Approach for the Treatment of Denegerative Disk Disease: Feasibility and Preliminary Results.

Authors:  Rudolf Morgenstern; Christian Morgenstern
Journal:  Int J Spine Surg       Date:  2015-07-27

Review 3.  Minimally invasive spine surgery: systematic review.

Authors:  Péter Banczerowski; Gábor Czigléczki; Zoltán Papp; Róbert Veres; Harry Zvi Rappaport; János Vajda
Journal:  Neurosurg Rev       Date:  2014-09-10       Impact factor: 3.042

Review 4.  Minimally invasive spine surgery for degenerative spine disease and deformity correction: a literature review.

Authors:  Marios G Lykissas; Dionysios Giannoulis
Journal:  Ann Transl Med       Date:  2018-03

5.  Fusion rate and influence of surgery-related factors in lumbar interbody arthrodesis for degenerative spine diseases: a meta-analysis and systematic review.

Authors:  M Formica; D Vallerga; A Zanirato; L Cavagnaro; M Basso; S Divano; L Mosconi; E Quarto; G Siri; L Felli
Journal:  Musculoskelet Surg       Date:  2020-01-01

Review 6.  Clinical outcomes after minimally invasive transforaminal lumbar interbody fusion and lateral lumbar interbody fusion for treatment of degenerative lumbar disease: a systematic review and meta-analysis.

Authors:  Gun Keorochana; Kitipong Setrkraising; Patarawan Woratanarat; Alisara Arirachakaran; Jatupon Kongtharvonskul
Journal:  Neurosurg Rev       Date:  2016-12-24       Impact factor: 3.042

7.  Microendoscopy-assisted minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease: short-term and medium-term outcomes.

Authors:  Yang Yang; Bin Liu; Li-Min Rong; Rui-Qiang Chen; Jian-Wen Dong; Pei-Gen Xie; Liang-Ming Zhang; Feng Feng
Journal:  Int J Clin Exp Med       Date:  2015-11-15

8.  [Comparison of minimally invasive transforaminal lumbar interbody fusion between two approaches in treatment of single-segment lumbar spinal stenosis].

Authors:  Rui Zhong; Runsheng Wang; Jianheng Liu; Zhenchuan Han; Wei Jiang; Qingzu Liu; Keya Mao
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-07-15

9.  Feasibility of Full Percutaneous Segmental Stabilization of the Lumbar Spine With a Combination of an Expandable Interbody Cage and an Interspinous Spacer: Preliminary Results.

Authors:  Rudolf Morgenstern; Christian Morgenstern
Journal:  Int J Spine Surg       Date:  2018-12-21

10.  CORR Insights®: Elderly Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion May Have Similar Clinical Outcomes, Perioperative Complications, and Fusion Rates As Their Younger Counterparts.

Authors:  J Brian Gill
Journal:  Clin Orthop Relat Res       Date:  2020-04       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.